269 related articles for article (PubMed ID: 19718488)
1. [Spice drugs: cannabinoids as a new designer drugs].
Mustata C; Torrens M; Pardo R; Pérez C; ; Farré M
Adicciones; 2009; 21(3):181-6. PubMed ID: 19718488
[TBL] [Abstract][Full Text] [Related]
2. [Spice in France: mixed herbs containing synthetic cannabinoids].
Schlatter J; Chiadmi F; Chariot P
Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613
[TBL] [Abstract][Full Text] [Related]
3. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
Dresen S; Ferreirós N; Pütz M; Westphal F; Zimmermann R; Auwärter V
J Mass Spectrom; 2010 Oct; 45(10):1186-94. PubMed ID: 20857386
[TBL] [Abstract][Full Text] [Related]
4. Beyond THC: The New Generation of Cannabinoid Designer Drugs.
Fattore L; Fratta W
Front Behav Neurosci; 2011; 5():60. PubMed ID: 22007163
[TBL] [Abstract][Full Text] [Related]
5. Spice drugs as a new trend: mode of action, identification and legislation.
Vardakou I; Pistos C; Spiliopoulou Ch
Toxicol Lett; 2010 Sep; 197(3):157-62. PubMed ID: 20566335
[TBL] [Abstract][Full Text] [Related]
6. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.
Seely KA; Lapoint J; Moran JH; Fattore L
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):234-43. PubMed ID: 22561602
[TBL] [Abstract][Full Text] [Related]
7. [Synthetic cannabinoids--the new "legal high" drugs].
Berkovitz R; Arieli M; Marom E
Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277
[TBL] [Abstract][Full Text] [Related]
8. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
[TBL] [Abstract][Full Text] [Related]
9. DNA sequence analyses of blended herbal products including synthetic cannabinoids as designer drugs.
Ogata J; Uchiyama N; Kikura-Hanajiri R; Goda Y
Forensic Sci Int; 2013 Apr; 227(1-3):33-41. PubMed ID: 23092848
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples.
Dresen S; Kneisel S; Weinmann W; Zimmermann R; Auwärter V
J Mass Spectrom; 2011 Feb; 46(2):163-71. PubMed ID: 21259394
[TBL] [Abstract][Full Text] [Related]
11. Spice/K2 drugs--more than innocent substitutes for marijuana.
Zawilska JB; Wojcieszak J
Int J Neuropsychopharmacol; 2014 Mar; 17(3):509-25. PubMed ID: 24169044
[TBL] [Abstract][Full Text] [Related]
12. [Effect and occurrence of synthetic cannabinoids].
Tuv SS; Strand MC; Karinen R; Øiestad EL; Christophersen AS; Vindenes V
Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2285-8. PubMed ID: 23736196
[TBL] [Abstract][Full Text] [Related]
13. The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice'.
Dargan PI; Hudson S; Ramsey J; Wood DM
Int J Drug Policy; 2011 Jul; 22(4):274-7. PubMed ID: 21482092
[TBL] [Abstract][Full Text] [Related]
14. The Synthetic Cannabinoids Phenomenon.
Karila L; Benyamina A; Blecha L; Cottencin O; Billieux J
Curr Pharm Des; 2016; 22(42):6420-6425. PubMed ID: 27655416
[TBL] [Abstract][Full Text] [Related]
15. The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review.
Alves VL; Gonçalves JL; Aguiar J; Teixeira HM; Câmara JS
Crit Rev Toxicol; 2020 May; 50(5):359-382. PubMed ID: 32530350
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Synthetic Cannabinoids in Botanical Material: A Review of Analytical Methods and Findings.
Presley BC; Jansen-Varnum SA; Logan BK
Forensic Sci Rev; 2013 Mar; 25(1-2):27-46. PubMed ID: 26226849
[TBL] [Abstract][Full Text] [Related]
17. ["Spice"--synthetic cannabinoids with dangerous effects].
Personne M; Westerbergh J; Hammer-Pettersen L
Lakartidningen; 2014 Nov; 111(47):2105-7. PubMed ID: 25386644
[TBL] [Abstract][Full Text] [Related]
18. Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry.
Shanks KG; Dahn T; Behonick G; Terrell A
J Anal Toxicol; 2012 Jul; 36(6):360-71. PubMed ID: 22586208
[TBL] [Abstract][Full Text] [Related]
19. Highly sensitive screening and analytical characterization of synthetic cannabinoids in nine different herbal mixtures.
Alves VL; Gonçalves JL; Aguiar J; Caldeira MJ; Teixeira HM; Câmara JS
Anal Bioanal Chem; 2021 Mar; 413(8):2257-2273. PubMed ID: 33575815
[TBL] [Abstract][Full Text] [Related]
20. Detection and quantification of new designer drugs in human blood: Part 1 - Synthetic cannabinoids.
Ammann J; McLaren JM; Gerostamoulos D; Beyer J
J Anal Toxicol; 2012 Jul; 36(6):372-80. PubMed ID: 22593567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
